Latest Breaking News On - Richard rudick - Page 1 : comparemela.com

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Immunic Highlights 2023 Accomplishments and Upcoming Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoEdna kaplanHella kohlhofRichard rudickDaniel vittJessica breuPaula schwartzProgram in relapsing multiple sclerosis ongoingPrnewswire immunic incJp morgan health care conferenceExchange commissionRx communications groupCorporate communityImmunic incInternational business gold award

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoPaula schwartzDaniel vittJessica breuRichard rudickEdna kaplanHella kohlhofExchange commissionJp morgan health care conferenceCorporate communityImmunic inc nasdaqProgram in relapsing multiple sclerosis ongoingInternational business gold awardDistribution servicesImmunic inc

Immunic, Inc Reports Second Quarter 2023 Financial Results and Provides Corporate Update

– Preclinical Data Published in the Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator, Reinforcing Neuroprotective.

Paula schwartzDaniel vittJessica breuEdna kaplanVincent ossipowRichard rudickDevelopment rd expensesRx communications groupExchange commissionPrnewswire immunic incImmunic incPreclinical data publishedPotent nurrReinforcing neuroprotective potentialMultiple sclerosisPositive results from phase

Immunic, Inc (NASDAQ:IMUX) Q1 2023 Earnings Call Transcript

Jessica Breu: Good morning, and welcome to Immunic s First Quarter 2023 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.

United statesDaniel vittJessica breuBob foxMichael schumannGlenn whaleyRichard rudickVincent ossipowJoseph murrayImmunic incCall transcript mayFirst quarterInvestor relationsChief executive officerChief financialCeliac disease rd webcast

Immunic, Inc Reports First Quarter 2023 Financial Results and Provides Corporate Update

– Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease Provide Proof-of-Concept for a New Therapeutic Approach to Treat Gastrointestinal.

United statesRichard rudickJosepha murrayPaula schwartzEdna kaplanRobertj foxJessica breuVincent ossipowMichael schumannDaniel vittAmericas committee for treatmentRx communications groupExchange commissionMellen centerDevelopment rd expensesImmunic inc